# US 2008/0188404 A1 · Hybrid And Chimeric Polypeptides That Regulate Activation Of Complement

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188404 A1
- Document ID: US20080188404A1
- Status: Published application
- Kind: A1
- Application number: 10/597,373
- Filed: 2005-01-21
- Published: 2008-08-07
- Earliest claimed: 2004-01-21
- Assignees: Case Western Reserve University
- Inventors: Edward M. Medof; Lisa Kuttner-Kondo
- Web page: https://patentgrep.com/patent/US20080188404A1

## CPC

- C07K 14/70596: {Molecules with a "CD"-designation not provided for elsewhere}
- A61P 37/00: Drugs for immunological or allergic disorders
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A hybrid complement-regulating protein comprises a first functional unit of a first complement regulatory protein having complement regulating properties, a first spacer sequence of at least about 200 amino acids encoding a polypeptide that does not exhibit complement regulating properties and at least a second functional unit attached to the spacer sequence. The second functional unit may be a polypeptide providing a functional unit of a second complement regulatory protein, a polypeptide derived from an immunoglobulin, or a polypeptide that enhances binding of the protein to an animal cell. The hybrid protein may also contain a second spacer sequence and a third functional unit of a complement regulatory protein, a polypeptide derived from an immunoglobulin, and a polypeptide that enhances binding of the protein to an animal cell. The optional third functional unit may be the same or different from the first or second functional units.

## Claims

### Claim 1

A protein comprising:
a first functional unit of a first complement regulatory protein, wherein the first functional unit exhibits complement-regulating properties;
a first spacer sequence of at least about 200 amino acids encoding a polypeptide that does not exhibit complement regulating properties, attached to the first functional unit; and
a second functional unit attached to the spacer sequence, selected from the group consisting of polypeptides providing a functional unit of a second complement regulatory protein, polypeptides derived from an immunoglobulin, and polypeptides that enhance binding of the protein to an animal cell.

### Claim 2 (depends on 1)

The protein of claim 1, additionally comprising a second spacer sequence of at least about 200 amino acids encoding a polypeptide that does not exhibit complement regulating properties attached to the second function domain, and a third functional unit attached to the second spacer, wherein the third functional unit is selected from the group consisting of polypeptides derived from an immunoglobulin, and polypeptides that enhance binding of the protein to an animal cell.

### Claim 3 (depends on 1)

The protein of claim 1, wherein the first functional unit comprises at least CCPs 2, 3 and 4 of DAF.

### Claim 4 (depends on 1)

The protein of claim 1, wherein the second functional unit is selected from the group consisting of CCPs 8-10 of Complement Receptor 1 (CR1), CCPs 15-17 of CR1, CCPs 1-4 of Membrane Cofactor Protein (MCP), polypeptides derived from IgG4, and a lipid tail.

### Claim 5 (depends on 1, 2, 3, 4)

The protein of any of claims 1-4, wherein the spacers are selected from the group consisting of substantially all of the amino acids of CCPs 4-7 of CR1, and substantially all of the amino acids of CCPs 11-14 of CR1.

### Claim 6 (depends on 1)

The protein of claim 1, wherein the first functional unit comprises CCPs 1, 2, 3 and 4 of DAF, the second functional unit is selected from the group consisting of CCPs 8-10 of CR1, CCPs 1-4 of Membrane Cofactor Protein (MCP), and polypeptides derived from IgG4, and the first spacer is substantially all of the amino acids of CCPs 4-7 of CR1.

### Claim 7 (depends on 6)

The protein of claim 6, additionally comprising a second spacer comprising substantially all of the amino acids of CCPs 4-5 of CR1, and a third functional unit selected from the group consisting of CCPs 8-10 of CR1 CCPs 1-4 of MCP, and polypeptides derived from IgG4.

### Claim 8 (depends on 6)

A polynucleotide encoding the protein of claim 6.

### Claim 9 (depends on 7)

A polynucleotide encoding the protein of claim 7.

### Claim 10 (depends on 1)

A polynucleotide encoding the protein of claim 1.

### Claim 11 (depends on 10)

A vector comprising the polynucleotide of claim 10.

### Claim 12

A protein having at least 95 percent sequence homology to a protein selected from the group consisting of proteins having the sequence of SEQ. ID NO: 13, SEQ. ID NO: 15, SEQ. ID NO: 19, and SEQ. ID NO: 23.

### Claim 13 (depends on 11)

A polynucleotide encoding the protein of claim 11.

### Claim 14 (depends on 1)

A method of regulating complement activity comprising administering an effective amount of protein of claim 1 to a mammal.

### Claim 15 (depends on 15)

The method of claim 15, wherein the mammal is a human.
